Scarica l'app Stockscreener
38.39
3.07%
1.0677
Sutro Biopharma Inc Borsa (STRO) Ultime notizie
Sutro Biopharma (NASDAQ:STRO) Upgraded at Lifesci Capital - MarketBeat
Citizens Raises Sutro Biopharma Price Target to 41 Dollars - HarianBasis.co
Point72 group (NASDAQ: STRO) reports 5.7% stake — 946,829 shares - Stock Titan
Sutro Biopharma (NASDAQ:STRO) Upgraded by Mizuho to "Strong-Buy" Rating - MarketBeat
Citizens Lifts PT on Sutro Biopharma (STRO) on Its Pipeline and Lead Program - Insider Monkey
Mizuho initiates coverage of Sutro Biopharma (STRO) with outperform recommendation - MSN
Sutro Biopharma: Recycling Past Data Ahead Of The Readout, Sell - Seeking Alpha
MSN Money - MSN
This Palantir Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Thursday - Benzinga
Mizuho Securities Initiates Sutro Biopharma(STRO.US) With Buy Rating, Announces Target Price $50 - Moomoo
Short Interest in Sutro Biopharma, Inc. (NASDAQ:STRO) Grows By 17.0% - MarketBeat
Mizuho Initiates Sutro Biopharma at Outperform With $50 Price Target - marketscreener.com
STRO Initiated Coverage by Mizuho -- Rating Set at Outperform - GuruFocus
Mizuho initiates Sutro Biopharma stock coverage with outperform rating By Investing.com - Investing.com India
Mizuho initiates Sutro Biopharma stock coverage with outperform rating - Investing.com
Sutro Biopharma (NASDAQ:STRO) Hits New 1-Year HighWhat's Next? - MarketBeat
Sutro Biopharma Strengthens Financial Position and Advances ADC Pipeline - HarianBasis.co
Here is Why Sutro Biopharma (STRO) is One of the Tiny Stocks That Are On Fire Right Now - Insider Monkey
5 Tiny Stocks That Are On Fire Right Now - Insider Monkey
Sutro Biopharma (NASDAQ:STRO) Shares Up 5.6%What's Next? - MarketBeat
Sutro Biopharma (STRO) price target decreased by 21.62% to 29.58 - MSN
Sutro Biopharma prices $110M common stock offering - MSN
Sutro Biopharma, Inc. (STRO) Presents at AACR Annual Meeting 2026Slideshow (NASDAQ:STRO) 2026-04-24 - Seeking Alpha
Sutro Biopharma (NASDAQ:STRO) Shares Down 6.1%Time to Sell? - MarketBeat
STRO Maintains by Citizens -- Price Target Raised to $41.00 - GuruFocus
Citizens Jmp Boosts Sutro Biopharma (NASDAQ:STRO) Price Target to $41.00 - MarketBeat
Citizens raises Sutro Biopharma stock price target on platform value By Investing.com - Investing.com Canada
Citizens JMP Maintains Sutro Biopharma(STRO.US) With Buy Rating, Raises Target Price to $41 - Moomoo
STRO (Sutro Biopharma Inc.) posts 65.2 percent year over year revenue growth but misses EPS estimates, sending shares slightly lower.Restructuring - Cổng thông tin điện tử tỉnh Lào Cai
STRO Sutro Biopharma Q4 2025 EPS misses estimates, shares rise 3.01 percent on strong 65.2 percent revenue growth.High Interest Stocks - Xã Thanh Hà
Sutro Biopharma (NASDAQ: STRO) outlines 2026 vote on board, pay and auditor - Stock Titan
STRO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Millennium entities report 210,378 shares in Sutro Biopharma (STRO) — joint filing - Stock Titan
Perceptive Advisors, Joseph Edelman report 5.4% stake in Sutro Biopharma (NASDAQ: STRO) - Stock Titan
Sutro Biopharma (NASDAQ:STRO) Reaches New 1-Year HighStill a Buy? - MarketBeat
Sutro Biopharma, Inc. $STRO Shares Sold by JPMorgan Chase & Co. - MarketBeat
Sutro Biopharma presents promising preclinical data on ADC pipeline at AACR Annual Meeting - Traders Union
Sutro Biopharma (STRO) Reveals Strong Preclinical Results for Ne - GuruFocus
Sutro Biopharma Presents Promising Preclinical Data For Pipeline ADC Programs At AACR 2026 - RTTNews
Sutro Biopharma Presents Promising Preclinical Data Across its Pipeline of Next-Generation Single and Dual-Payload ADC Programs at AACR 2026 - The Manila Times
Sutro Biopharma Reports Promising Preclinical Data for Next-Generation ADCs STRO-004, STRO-006, and STRO-227 at AACR Annual Meeting 2026 - Quiver Quantitative
Sutro's cancer drug candidate outperformed benchmark ADCs in lab models - Stock Titan
Sutro Biopharma, Inc. (NASDAQ:STRO) Short Interest Up 20.1% in March - MarketBeat
Sutro Biopharma (NASDAQ:STRO) Trading Up 10.4% After Analyst Upgrade - MarketBeat
STRO Maintained by Citizens -- Price Target Raised to $35.00 - GuruFocus
Sutro Biopharma (NASDAQ:STRO) Stock Price Expected to Rise, Citizens Jmp Analyst Says - MarketBeat
Citizens raises Sutro Biopharma stock price target on pipeline value By Investing.com - Investing.com Canada
Citizens JMP Maintains Sutro Biopharma(STRO.US) With Buy Rating, Raises Target Price to $35 - Moomoo
Sutro Biopharma Hits New 52-Week High - National Today
Sutro Biopharma (NASDAQ:STRO) Reaches New 52-Week HighHere's What Happened - MarketBeat
0.78%
3.01%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):